source
- Eli Lilly signs up to $370 million ion-channel collaboration with OmniAbEli Lilly announced a collaboration and licensing agreement with California-based drug discovery company OmniAb that will focus on ion-channel targets. The deal could see Lilly paying up to $370 m…
- Drugmakers Back US Probe into Germany’s New Drug Pricing PoliciesSeven major pharmaceutical companies, together with industry groups PhRMA and BIO, have urged the German government to amend its recently introduced drug‑pricing reforms. The coalition voiced supp…